Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples